Quest Diagnostics (DGX) Earnings Analysis

Quest Diagnostics (DGX) next reports earnings on 2026-10-27, consensus EPS 2.8 USD. Last quarter (2026-07-23) it beat with EPS 3.12 USD vs 2.82 USD est (+10.6%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 22.88.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DGX next report earnings?

Next earnings date2026-10-27
Consensus EPS estimate2.8 USD
Revenue estimate3.01B

DGX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-233.12 USD2.82 USD+10.6%Beat
2025-10-212.6 USD2.5 USD+4%Beat
2025-07-222.62 USD2.57 USD+1.9%Beat
2025-01-302.23 USD2.19 USD+1.8%Beat
2024-07-232.35 USD2.34 USD+0.4%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

DGX valuation and analyst view

Trailing P/E22.88
Trailing EPS9.309 USD
Price / book3.13
Dividend yield1.58%
Market cap22.90B
Analyst consensusHold (13 buy / 18 hold / 3 sell)
Avg price target236 USD

Related research pages

Frequently asked questions

When is Quest Diagnostics (DGX)'s next earnings date?

Quest Diagnostics is next scheduled to report on 2026-10-27, with a consensus EPS estimate of 2.8 USD and revenue estimate of 3.01B.

Did DGX beat earnings last quarter?

In its 2026-07-23 report, DGX posted EPS of 3.12 USD versus a 2.82 USD estimate — a beat of 10.6%.

What is DGX's earnings track record?

Over the last 5 reported quarters with consensus data, DGX beat estimates 5 times (100%).

What is DGX's current P/E ratio and EPS?

DGX trades at a trailing P/E of 22.88 on trailing EPS of 9.309090909090909 USD.

What do analysts rate DGX?

Analyst consensus is "Hold" across 34 ratings (0 strong buy, 13 buy, 18 hold, 3 sell, 0 strong sell). Average 12-month price target: 236 USD.